Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
about
Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacologycis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsHepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 geneGenetic analysis of OCT1 gene polymorphisms in an Indian populationA novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveriesThe role of variants regulating metformin transport and action in women with polycystic ovary syndrome.Genetic diversity and function in the human cytosolic sulfotransferases.Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.The use of orthologous sequences to predict the impact of amino acid substitutions on protein function.PharmGKB summary: very important pharmacogene information for SLC22A1Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Molecular modeling and ligand docking for solute carrier (SLC) transportersStereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography.Comparison of human solute carriersGenetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South AfricaHuman serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase.An update on the pharmacogenomics of metformin: progress, problems and potential.Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.Uptake of pramipexole by human organic cation transporters.Expression of mRNA transcripts encoding membrane transporters detected with whole transcriptome sequencing of human brain and liverThe pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function.Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study.Functional genomics of membrane transporters in human populations.The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.The pharmacogenetics of imanitib.Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.Natural variation in human membrane transporter genes reveals evolutionary and functional constraintsStructure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.Genetic variation of COLEC10 and COLEC11 and association with serum levels of collectin liver 1 (CL-L1) and collectin kidney 1 (CL-K1)Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCXEffect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionPharmacogenetics of metformin response: a step in the path toward personalized medicineGlobal genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1.Molecular and cellular physiology of renal organic cation and anion transport.Characterization of Disease-Associated Mutations in Human Transmembrane ProteinsPharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1).Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.
P2860
Q27026858-1BA1635C-9542-4E93-A09C-9D05AEAC2720Q27650949-2A1FA5FA-9524-4BAF-AA6E-76221E07A24FQ28296115-4C42872F-F1C0-4151-82B0-02373EAE8035Q28732156-0CCE2844-3798-49C2-8BF2-DDC8E2DB9AEFQ28820987-55D488A8-DEA2-4B2C-A7CC-D3DE15AD5A68Q30275579-107E8102-373F-432D-ADDF-5BE6426609F6Q30355169-72CC1C97-A38E-4DBE-800E-E490E9092D68Q33351201-656FBB93-2E10-4FD1-847C-1AEFE366033CQ33480591-089898EC-6149-42EC-81BF-44A6508BAC66Q33594401-0C2FFA3E-EA30-42AE-BF66-C607D43B5103Q33671763-514879E2-C470-4BF7-816C-DC881DA59AF7Q33714593-586D8BB4-0D5C-45AE-8161-5BAAB9742EC1Q33751096-91CADCC0-9327-425D-B045-0C7307F222B2Q33788019-92B57559-C2BF-4C05-B45F-3AD778C4EA6BQ33836276-FB47776E-BE5E-46A0-824C-C3F1D3197B00Q33890370-F447B60A-7A61-4AA0-AA28-37183F4DAE14Q33913931-E646D27F-600E-4796-A3EA-5CD410F42A08Q34003050-A76A9084-5020-4FCE-B389-7E5AE7D623E0Q34025097-CE1D4288-1E8B-4900-AACD-A442B163D163Q34037009-760F9A75-48E9-48C4-B5D9-9D8F2E3C115CQ34042444-ED855FBD-19CA-4DE4-BBC3-94E1E9F26435Q34071782-DB8343FB-6BAE-4F08-8A9B-A6AC1E17AACAQ34170589-5585446D-B37C-4D4B-A921-0449D5DA06D0Q34292544-3BC96A51-0BF4-4CA4-B7F4-8FD54DA41A7DQ34335929-B6156270-87DF-44D0-8645-22D503CFE7D6Q34338845-370D01C8-842E-4B8A-BDE1-1178F9B4FC1DQ34468094-60453FA6-3777-4898-861B-53524DD42FFFQ34469295-0BF0661F-7F01-4374-97F5-D4657B163A49Q34777362-EF9FCFA6-965E-4187-B6FA-D58E23090905Q35022362-31B97579-8DB8-45A7-945A-ED544DD2167DQ35229337-5D7FA6FB-FEA7-4641-AE69-B53D73FC4DE5Q35567031-A507405D-FF56-4649-82BB-993AC6399880Q35706472-79160CBD-0EBD-4A9C-AC4F-82AE9B28F4FAQ35762110-ADC1A119-60F1-4AD7-BD0F-956D1E5F0E18Q35762123-FCC05FDD-8384-44DE-9FBC-1809E52F6092Q35831346-ADAD1F73-2094-4B32-BABE-DD2F1064CF4FQ35842999-52448B3C-690C-4314-8DEB-A8CABB18DC74Q35960743-CA4E26BE-BDE4-4C07-B1E6-F8BEBCD28340Q36358068-89B9B0A4-CA22-4605-89D0-422C68A4E1FDQ36609738-FB8B2362-3BD1-404B-86D1-0D6E3C61223D
P2860
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@ast
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@en
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@nl
type
label
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@ast
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@en
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@nl
prefLabel
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@ast
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@en
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@nl
P2093
P2860
P3181
P356
P1476
Evolutionary conservation pred ...... ganic cation transporter, OCT1
@en
P2093
Conrad C Huang
Doug Stryke
Elaine Carlson
Ira Herskowitz
Joseph DeYoung
Kathleen M Giacomini
Maya K Leabman
Michiko Kawamoto
Susan J Johns
P2860
P304
P3181
P356
10.1073/PNAS.0730858100
P407
P577
2003-05-13T00:00:00Z